India immunology drugs market is expected
to grow at a formidable rate during the forecast period. The India immunology
drugs market is driven by high prevalence of immunological as well as
autoimmune disorders in the country. Additionally, increasing adoption of
monoclonal antibody for treating immunological diseases is further expected to
boost the demand through FY2026. Improvement in healthcare infrastructure
coupled with continuous advancements in drug manufacturing is further predicted
to bolster the market growth in the years to come.
The India immunology drugs market is
segmented based on drug class, indication, application, company, and region.
Based on drug class, the market is segmented into monoclonal antibodies (mAb),
antibody drug conjugates, interferon and cytokine therapies, immunosuppressive medication,
others. Among them, the monoclonal antibodies segment dominated the market
until FY2020 and is further projected to maintain its dominance in the market
during the forecast years as well on account of growing research and
developmental initiatives in monoclonal antibodies. Also, the immunosuppressive
medication segment is anticipated to register high CAGR in the market over the
next 5 years which can be accredited to increased revenue for this drug class
and high achievement rates in terms of patient treatment.
The major players
operating in the India immunology drugs market are Panacea Biotec Ltd., Bristol
Myers Squibb India Pvt. Ltd., Wockhardt Ltd., Pfizer Limited, Sanofi India Ltd.,
GlaxoSmithKline Pharmaceuticals Ltd., Abbott India Ltd., Genentech (Roche)
India Pvt. Ltd., Novartis India Ltd., Allergan India Private Limited and others.
Major companies are developing advanced technologies, receiving approvals from
regulatory bodies, and launching new products in order to stay competitive in
the market. Other inorganic growth strategies include mergers &
acquisitions, joint ventures, and new product developments in order to sustain
themselves amidst fierce competition.
Years considered for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022–FY2026
Objective of the
Study:
- To analyze and estimate the market size of India
immunology drugs market from FY2016 to FY2019.
- To estimate and forecast the market size of India
immunology drugs market from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India immunology
drugs market based on drug class, indication, application, company, and
regional distribution.
- To identify dominant region or segment in the India
immunology drugs market.
- To identify drivers and challenges for India immunology
drugs market.
- To examine competitive developments such as
expansions, new product launches, mergers & acquisitions, etc., in India
immunology drugs market.
- To identify and analyze the profile of leading
players operating in India immunology drugs market.
- To identify key sustainable strategies adopted
by market players in India immunology drugs market.
Click here to download the sample
TechSci Research performed both primary as well as
exhaustive secondary research for this study. Initially, TechSci Research
sourced a list of manufacturers across the globe. Subsequently, TechSci
Research conducted primary research surveys with the identified companies.
While interviewing, the respondents were also enquired about their competitors.
Through this technique, TechSci Research could include the manufacturers which
could not be identified due to the limitations of secondary research. TechSci
Research analyzed the manufacturers, distribution channels and presence of all
major players across the globe.
TechSci Research calculated the market size of India immunology drugs market using a bottom-up approach, wherein data for various end-user
segments was recorded and forecast for the future years. TechSci Research
sourced these values from the industry experts and company representatives and
externally validated through analyzing historical data of these product types
and applications for getting an appropriate, overall market size. Various
secondary sources such as company websites, news articles, press releases,
company annual reports, investor presentations and financial reports were also studied
by TechSci Research.
Key Target Audience:
- Immunology drugs manufacturers/
suppliers/ distributors
- Market research and
consulting firms
- Government bodies such as
regulating authorities and policy makers
- Organizations, forums and
alliances related to immunology drugs
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as manufacturers, suppliers and partners, end users, etc., besides
allowing them in strategizing investments and capitalizing on market
opportunities.
Report Scope:
In this report, India immunology
drugs market has been segmented into following categories, in addition to
the industry trends which have also been detailed below:
- India Immunology Drugs Market, By Drug Class:
- Monoclonal Antibodies (mAb)
- Antibody Drug Conjugates
- Interferon and Cytokine Therapies
- Immunosuppressive Medication
- Others
- India Immunology Drugs Market, By Indication:
- In- Arthritis
- Plaque Psoriasis
- Spondylitis
- Inflammatory Bowel Disease
- Transplant Rejection
- Others
- India Immunology Drugs Market, By Application:
- Hospitals
- Clinics
- Cancer
Research Institute
- Others
- India Immunology Drugs Market, By Region:
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in India immunology drugs market.
Available
Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed
analysis and profiling of additional market players (up to five).
India immunology drugs
market is an upcoming report to be released soon. If you wish an early delivery
of this report or want to confirm the date of release, please contact us at [email protected]